Robert E. Roses
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert E. Roses has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
Douglas L. Fraker
Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
12 shared publicationsGiorgos C. Karakousis
Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
11 shared publicationsJashodeep Datta
Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
11 shared publicationsJeffrey A. Drebin
Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
10 shared publications- Matthew T. McMillan
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
9 shared publications Ronac Mamtani
Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
6 shared publications
Latest Publications
- 20 November 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (3) , 864-865
ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors
- 20 November 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (3) , 864-865
ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors
- 7 November 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (3) , 855-863
Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors
Small (< 2 cm) and diminutive (< 1 cm) rectal neuroendocrine tumors (RNETs) are often described as indolent lesions. A large single-center experience was reviewed to determine the incidence of metastasis and the risk factors for its occurrence.
- 7 November 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (3) , 855-863
Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors
Small (< 2 cm) and diminutive (< 1 cm) rectal neuroendocrine tumors (RNETs) are often described as indolent lesions. A large single-center experience was reviewed to determine the incidence of metastasis and the risk factors for its occurrence.
- 1 June 2019
- Published by Elsevier in Surgical Clinics of North America
- Vol. 99 (3) , 439-456
Management of Early Stage Gastric and Gastroesophageal Junction Malignancies
- 1 June 2019
- Published by Elsevier in Surgical Clinics of North America
- Vol. 99 (3) , 439-456
Management of Early Stage Gastric and Gastroesophageal Junction Malignancies
- 17 January 2019
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 03 (01) , 030-037
Surgery for Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases
Gastroenteropancreatic-neuroendocrine tumors (GEP-NETs) arise from endocrine cell types along the luminal gastrointestinal tract and pancreas. Stage and grade are dominant predictors of outcome. Optimal management of localized, lower-grade GEP-NETs involves surgical resection, which is associated with excellent long-term survival. While high-grade disease is almost always associated with rapid disseminated progression, metastatic, well-differentiated GEP-NETs can progress slowly and are compatible with prolonged survival. Management of patients with an advanced spectrum of lower grade disease can include a range of systemic and local therapies and requires multidisciplinary collaboration. While controversy persists regarding the optimal scope and sequencing of therapy, surgical management can have a substantial impact alone or in combination with other therapies.
- 17 January 2019
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 03 (01) , 030-037
Surgery for Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases
Gastroenteropancreatic-neuroendocrine tumors (GEP-NETs) arise from endocrine cell types along the luminal gastrointestinal tract and pancreas. Stage and grade are dominant predictors of outcome. Optimal management of localized, lower-grade GEP-NETs involves surgical resection, which is associated with excellent long-term survival. While high-grade disease is almost always associated with rapid disseminated progression, metastatic, well-differentiated GEP-NETs can progress slowly and are compatible with prolonged survival. Management of patients with an advanced spectrum of lower grade disease can include a range of systemic and local therapies and requires multidisciplinary collaboration. While controversy persists regarding the optimal scope and sequencing of therapy, surgical management can have a substantial impact alone or in combination with other therapies.
- 1 October 2018
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 27 (4) , 705-715
Malignant Bowel Obstruction
- 1 October 2018
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 27 (4) , 705-715
Malignant Bowel Obstruction
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-933-933
Tu1320 - The Prevalence and Incidence of Neoplasia in Patients with Autoimmune Metaplastic Atrophic Gastritis: A Renewed Case for Surveillance Endoscopy
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-933-933
Tu1320 - The Prevalence and Incidence of Neoplasia in Patients with Autoimmune Metaplastic Atrophic Gastritis: A Renewed Case for Surveillance Endoscopy
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
411 - Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
411 - Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy
- 21 June 2017
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 21 (11) , 1957-1958
Giant Caudate Lobe Hemangioma
- 21 June 2017
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 21 (11) , 1957-1958
Giant Caudate Lobe Hemangioma
- Open Access
- 23 March 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (5) , 621-624
Staged management of giant bilateral perinephric adipocytic neoplasms
Key Clinical Message: We present a patient with giant bilateral perinephric masses favored to represent liposarcoma preoperatively. Bilateral renal involvement posed a clinical challenge; careful histologic assessment and surgical planning allowed preservation of renal function.
- 23 March 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (5) , 621-624
Open AccessStaged management of giant bilateral perinephric adipocytic neoplasms
Key Clinical Message: We present a patient with giant bilateral perinephric masses favored to represent liposarcoma preoperatively. Bilateral renal involvement posed a clinical challenge; careful histologic assessment and surgical planning allowed preservation of renal function.
- 1 December 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 69, 135-141
Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study
- 1 December 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 69, 135-141
Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study